Bromios Biotech Consulting is led by Julian Laurens, PhD, a neuroscientist with hands-on experience in experimental biology, and several years working on patent searches and freedom-to-operate analysis in the life sciences.
For early-stage biotech and med-tech teams, IP is often the only real asset long before revenue or clinical data. Investors, partners and acquirers will scrutinize your patent position and FTO.
We help you walk into those conversations prepared—with realistic, technically grounded insight into your IP landscape, delivered in a format a small team can actually use.
- Focus: antibody, peptide, gene/cell therapy, delivery systems and related biotech
- Clients: seed to Series B startups, university spin-outs, and small IP firms
- Work: FTO, prior-art, landscapes and IP-supporting research (not litigation)